{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:51:38Z","timestamp":1774659098958,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:00:00Z","timestamp":1518739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00345-018-2217-7","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T15:49:08Z","timestamp":1518796148000},"page":"1007-1017","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Susan","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick N.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail A. R.","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0552-7402","authenticated-orcid":false,"given":"Matthew J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,16]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","volume":"186","author":"S Loeb","year":"2011","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-medicare. J Urol 186:1830\u20131834","journal-title":"J Urol"},{"key":"2217_CR2","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","volume":"179","author":"JS Wolf","year":"2008","unstructured":"Wolf JS, Bennett CJ, Dmochowski RR, Hollenbeck BK, Pearle MS, Schaeffer AJ (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 179:1379\u20131390","journal-title":"J Urol"},{"key":"2217_CR3","unstructured":"Grabe M, Bartoletti R, Bjerklund-Johansen TE et al (2014) Guidelines on urological infections. European Association of Urology (EAU), Arnhem. https:\/\/uroweb.org\/wp-content\/uploads\/19-Urological-infections_LR2.pdf . Accessed 10 June 2017"},{"key":"2217_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/iju.13161","volume":"23","author":"S Yamamoto","year":"2016","unstructured":"Yamamoto S, Shigemura K, Kiyota H, Wada K, Hayami H, Yasuda M, Takahashi S, Ishikawa K, Hamasuna R, Arakawa S, Matsumoto T (2016) Essential Japanese guidelines for the prevention of perioperative infections in the urological field: 2015 edition. Int J Urol 23:814\u2013824","journal-title":"Int J Urol"},{"key":"2217_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5489\/cuaj.10021","volume":"4","author":"A El-Hakim","year":"2010","unstructured":"El-Hakim A, Moussa S (2010) CUA guidelines on prostate biopsy methodology. Can Urol Assoc J 4:89","journal-title":"Can Urol Assoc J"},{"key":"2217_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006576.pub2","author":"EL Zani","year":"2011","unstructured":"Zani EL, Clark OA, Rodrigues Netto N Jr (2011) Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006576.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2217_CR7","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.juro.2016.11.081","volume":"197","author":"JA Halpern","year":"2016","unstructured":"Halpern JA, Sedrakyan A, Dinerman B, Hsu W-C, Mao J, Hu JC (2016) Indications, utilization and complications following prostate biopsy: a New York state analysis. J Urol 197:1020\u20131025","journal-title":"J Urol"},{"key":"2217_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/pcan.2016.36","volume":"19","author":"K Lahdensuo","year":"2016","unstructured":"Lahdensuo K, Rannikko A, Anttila VJ, Erickson A, Patari-Sampo A, Rautio M, Santti H, Tarkka E, Vaara M, Huotari K (2016) Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013: a population-based analysis. Prostate Cancer Prostatic Dis 19:417\u2013422","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2217_CR9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/pros.22979","volume":"75","author":"M Aly","year":"2015","unstructured":"Aly M, Dyrdak R, Nordstrom T, Jalal S, Weibull CE, Giske CG, Gronberg H (2015) Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-a 10-year population-based cohort study. Prostate 75:947\u2013956","journal-title":"Prostate"},{"key":"2217_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.eururo.2012.06.003","volume":"63","author":"FM Wagenlehner","year":"2013","unstructured":"Wagenlehner FM, van Oostrum E, Tenke P, Tandogdu Z, \u00c7ek M, Grabe M, Wullt B, Pickard R, Naber KG, Pilatz A, Weidner W, Bjerklund-Johansen TE (2013) Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 63:521\u2013527","journal-title":"Eur Urol"},{"key":"2217_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","volume":"11","author":"FME Wagenlehner","year":"2014","unstructured":"Wagenlehner FME, Pilatz A, Waliszewski P, Weidner W, Johansen TEB (2014) Reducing infection rates after prostate biopsy. Nat Rev Urol 11:80\u201386","journal-title":"Nat Rev Urol"},{"key":"2217_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","volume":"62","author":"A Carignan","year":"2012","unstructured":"Carignan A, Roussy J-F, Lapointe V, Valiquette L, Sabbagh R, P\u00e9pin J (2012) Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol 62:453\u2013459","journal-title":"Eur Urol"},{"key":"2217_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijantimicag.2014.01.008","volume":"43","author":"MJ Roberts","year":"2014","unstructured":"Roberts MJ, Williamson DA, Hadway P, Doi SAR, Gardiner RA, Paterson DL (2014) Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. Int J Antimicrob Agents 43:301\u2013309","journal-title":"Int J Antimicrob Agents"},{"key":"2217_CR14","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/cid\/ciu1129","volume":"60","author":"MA Liss","year":"2015","unstructured":"Liss MA, Johnson JR, Porter SB, Johnston B, Clabots C, Gillis K, Nseyo U, Holden M, Sakamoto K, Fierer J (2015) Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis 60:979\u2013987","journal-title":"Clin Infect Dis"},{"key":"2217_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.urology.2016.12.011","volume":"104","author":"MJ Roberts","year":"2017","unstructured":"Roberts MJ, Bennett HY, Harris PN, Holmes M, Grummet J, Naber K, Wagenlehner FME (2017) Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches. Urology 104:11\u201321","journal-title":"Urology"},{"key":"2217_CR16","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.juro.2013.12.026","volume":"191","author":"PR Womble","year":"2014","unstructured":"Womble PR, Dixon MW, Linsell SM, Ye Z, Montie JE, Lane BR, Miller DC, Burks FN (2014) Infection related hospitalizations after prostate biopsy in a statewide quality improvement collaborative. J Urol 191:1787\u20131792","journal-title":"J Urol"},{"key":"2217_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bju.13466","volume":"117","author":"MJ Roberts","year":"2016","unstructured":"Roberts MJ, Doi SA (2016) Prostate biopsy, targeted prophylaxis and infectious complications: a critique of methods used. BJU Int 117:719\u2013721","journal-title":"BJU Int"},{"key":"2217_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement. BMJ. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"BMJ"},{"key":"2217_CR19","unstructured":"Higgins JPT, Green, S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration Version 5.1.0"},{"key":"2217_CR20","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","volume":"65","author":"D Hoy","year":"2012","unstructured":"Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, Baker P, Smith E, Buchbinder R (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 65:934\u2013939","journal-title":"J Clin Epidemiol"},{"key":"2217_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/oxfordjournals.aje.a009981","volume":"150","author":"B Takkouche","year":"1999","unstructured":"Takkouche B, Cadarso-Suarez C, Spielgelman D (1999) Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 150:206","journal-title":"Am J Epidemiol"},{"key":"2217_CR22","series-title":"Series on epidemiology and public health","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-642-37131-8_15","volume-title":"Methods of clinical epidemiology","author":"AA Onitilo","year":"2013","unstructured":"Onitilo AA, Doi SAR, Barendregt JJ (2013) Meta-analysis II. In: Williams G, Doi SAR (eds) Methods of clinical epidemiology. Series on epidemiology and public health. Springer, Berlin, pp 253\u2013266"},{"key":"2217_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1017\/S0950268815002885","volume":"144","author":"HY Bennett","year":"2016","unstructured":"Bennett HY, Roberts MJ, Doi SAR, Gardiner RA (2016) The global burden of major infectious complications following prostate biopsy. Epidemiol Infect 144:1784\u20131791","journal-title":"Epidemiol Infect"},{"key":"2217_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cct.2015.05.009","volume":"45","author":"SAR Doi","year":"2015","unstructured":"Doi SAR, Barendregt JJ, Khan S, Thalib L, Williams GM (2015) Advances in the meta-analysis of heterogeneous clinical trials I: the inverse variance heterogeneity model. Contemp Clin Trials 45:130\u2013138","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"2217_CR25","first-page":"152","volume":"15","author":"SAR Doi","year":"2015","unstructured":"Doi SAR, Furuya-Kanamori L, Thalib L, Barendregt JJ (2017) Meta-analysis in evidence-based healthcare: a paradigm shift away from random effects is overdue. Int J Evid Based Healthc 15(4):152\u2013160","journal-title":"Int J Evid Based Healthc"},{"key":"2217_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.prnil.2016.06.001","volume":"4","author":"A Fahmy","year":"2016","unstructured":"Fahmy A, Rhashad H, Mohi M, Elabbadie A, Kotb A (2016) Optimizing prophylactic antibiotic regimen in patients admitted for\u00a0transrectal ultrasound-guided prostate biopsies: a prospective randomized study. Prostate Int 4:113\u2013117","journal-title":"Prostate Int"},{"key":"2217_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12879-017-2470-1","volume":"17","author":"TR Zembower","year":"2017","unstructured":"Zembower TR, Maxwell KM, Nadler RB, Cashy J, Scheetz MH, Qi C, Schaeffer AJ (2017) Evaluation of targeted antimicrobial prophylaxis for transrectal ultrasound guided prostate biopsy: a prospective cohort trial. BMC Infect Dis 17:401","journal-title":"BMC Infect Dis"},{"key":"2217_CR28","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00345-015-1571-y","volume":"33","author":"SJ Summers","year":"2015","unstructured":"Summers SJ, Patel DP, Hamilton BD, Presson AP, Fisher MA, Lowrance WT, Southwick AW (2015) An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. World J Urol 33:2001\u20132007","journal-title":"World J Urol"},{"key":"2217_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.urology.2011.09.057","volume":"79","author":"CA Duplessis","year":"2012","unstructured":"Duplessis CA, Bavaro M, Simons MP, Marguet C, Santomauro M, Auge B, Collard DA, Fierer J, Lesperance J (2012) Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79:556\u2013563","journal-title":"Urology"},{"key":"2217_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1128\/JCM.02158-12","volume":"51","author":"MA Liss","year":"2013","unstructured":"Liss MA, Nakamura KK, Peterson EM (2013) Comparison of broth enhancement to direct plating for screening of rectal cultures for ciprofloxacin-resistant Escherichia coli. J Clin Microbiol 51:249\u2013252","journal-title":"J Clin Microbiol"},{"key":"2217_CR31","first-page":"275","volume":"31","author":"S Budak","year":"2015","unstructured":"Budak S, Karakece E, Budak GG, Aydemir H, Kumsar S, Kose O, Sencelikel T, Ciftci IH, Saglam HS, Adsan O (2015) Detection of fluoroquinolone-resistant bacteria prior to transrectal prostate biopsy: analysis of stool samples facilitates targeted prophylaxis. Acta Medica Mediterranea 31:275\u2013279","journal-title":"Acta Medica Mediterranea"},{"key":"2217_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.juro.2015.03.110","volume":"194","author":"MA Liss","year":"2015","unstructured":"Liss MA, Kim W, Moskowitz D, Szabo RJ (2015) Comparative effectiveness of targeted vs empirical antibiotic prophylaxis to prevent sepsis from transrectal prostate biopsy: a retrospective analysis. J Urol 194:397\u2013402","journal-title":"J Urol"},{"key":"2217_CR33","doi-asserted-by":"publisher","first-page":"e0170319","DOI":"10.1371\/journal.pone.0170319","volume":"12","author":"L Boeri","year":"2017","unstructured":"Boeri L, Fontana M, Gallioli A, Zanetti SP, Catellani M, Longo F, Mangiarotti B, Montanari E (2017) Rectal culture-guided targeted antimicrobial prophylaxis reduces the incidence of post-operative infectious complications in men at high risk for infections submitted to transrectal ultrasound prostate biopsy -results of a cross-sectional study. PLoS ONE 12:e0170319","journal-title":"PLoS ONE"},{"key":"2217_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1159\/000448595","volume":"97","author":"CG Trujillo","year":"2016","unstructured":"Trujillo CG, Plata M, Caicedo JI, Cata\u00f1o Cata\u00f1o JG, Mari\u00f1o Alvarez AM, Castelblanco D, Robledo D (2016) Impact of rectal swabs on infectious complications after transrectal prostate biopsy. Urol Int 97:340\u2013346","journal-title":"Urol Int"},{"key":"2217_CR35","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187:1275\u20131279","journal-title":"J Urol"},{"key":"2217_CR36","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.juro.2012.11.015","volume":"189","author":"RK Nam","year":"2013","unstructured":"Nam RK, Saskin R, Lee Y, Liu Y, Law C, Klotz LH, Loblaw DA, Trachtenberg J, Stanimirovic A, Simor AE, Seth A, Urbach DR, Narod SA (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189:S12\u2013S18","journal-title":"J Urol"},{"key":"2217_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/bju.12382","volume":"112","author":"G Losco","year":"2013","unstructured":"Losco G, Studd R (2013) Post-TRUS sepsis: targeted use of prophylactic ertapenem for high-risk patients. BJU Int 112:7","journal-title":"BJU Int"},{"key":"2217_CR38","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nrurol.2017.73","volume":"14","author":"DK Pruthi","year":"2017","unstructured":"Pruthi DK, Liss MA (2017) Sepsis: prophylactic antibiotic for prostate biopsy: the carbapenem gamble. Nat Rev Urol 14:394\u2013396","journal-title":"Nat Rev Urol"},{"key":"2217_CR39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrurol.2015.199","volume":"12","author":"HM Zowawi","year":"2015","unstructured":"Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL (2015) The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol 12:570\u2013584","journal-title":"Nat Rev Urol"},{"key":"2217_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","volume":"198","author":"MA Liss","year":"2017","unstructured":"Liss MA, Ehdaie B, Loeb S, Meng MV, Raman JD, Spears V, Stroup SP (2017) An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy. J Urol 198:329\u2013334","journal-title":"J Urol"},{"key":"2217_CR41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","volume":"114","author":"JP Grummet","year":"2014","unstructured":"Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M, Moon DA, O\u2019Reilly M, Murphy D (2014) Sepsis and \u2018superbugs\u2019: should we favour the transperineal over the transrectal approach for prostate biopsy? BJU Int 114:384\u2013388","journal-title":"BJU Int"},{"key":"2217_CR42","unstructured":"Bonkat G, Pickard R, Bartoletti R, Bruyere F, Geerlings S, Wagenlehner F, Wullt B (2017) EAU guidelines. Urological infections. https:\/\/uroweb.org\/guideline\/urological-infections . Accessed 21 Sept 2017"},{"key":"2217_CR43","doi-asserted-by":"crossref","unstructured":"Roberts MJ, Scott S, Harris PN, Naber K, Wagenlehner FME, Doi SAR (2017) Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. World J Urol (in press)","DOI":"10.1007\/s00345-017-2163-9"},{"key":"2217_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.juro.2012.08.194","volume":"189","author":"M Adibi","year":"2013","unstructured":"Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y (2013) Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 189:535\u2013540","journal-title":"J Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2217-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2217-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T08:10:12Z","timestamp":1719821412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2217-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,16]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2217-7","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,16]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors. Included studies report institutional ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained where appropriate within the included manuscripts included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}